Literature DB >> 31319080

Evaluating the discordant relationship between Tarlov cysts and symptoms of pudendal neuralgia.

Victoria M Lim1, Rohit Khanna2, Olga Kalinkin2, Mario E Castellanos3, Michael Hibner3.   

Abstract

BACKGROUND: Pudendal neuralgia is a painful neuropathic condition involving the pudendal nerve dermatome. Tarlov cysts have been reported in the literature as another potential cause of chronic lumbosacral and pelvic pain. Notably, they are often located in the distribution of the pudendal nerve origin at the S2, S3, and S4 sacral nerve roots and it has been postulated that they may cause similar symptoms to pudendal neuralgia. Literature has been inconsistent on the clinical relevance of the cysts and if they are responsible for symptoms.
OBJECTIVE: To evaluate the prevalence of S2-S4 Tarlov cysts at the pudendal nerve origin (S2-S4 sacral nerve roots) in patients specifically diagnosed with pudendal neuralgia, and establish association of patient symptoms with location of Tarlov cyst. STUDY
DESIGN: A retrospective study was performed on 242 patients with pudendal neuralgia referred for pelvic magnetic resonance imaging from January 2010 to November 2012. Dedicated magnetic resonance imaging review evaluated for presence, level, site, and size of Tarlov cysts. Among those with demonstrable cysts, subsequent imaging data were collected and correlated with the patients' clinical site of symptoms. Statistical analysis was performed using χ2, Pearson χ2, and Fisher exact tests to assess significance.
RESULTS: Thirty-nine (16.1%) patients demonstrated at least 1 sacral Tarlov cyst; and of the 38 patients with complete pain records, 31 (81.6%) had a mismatch in findings. A total of 50 Tarlov cysts were identified in the entire patient cohort. The majority of the Tarlov cysts were found at the S2-S3 level (32/50; 64%). Seventeen patients (44.7%) revealed unilateral discordant findings: unilateral symptoms on the opposite side as the Tarlov cyst. In addition, 14 (36.8%) patients were detected with bilateral discordant findings: 11 (28.9%) had bilateral symptoms with a unilateral Tarlov cyst, and 3 (7.9%) had unilateral symptoms with bilateral cysts. Concordant findings were only demonstrated in 7 patients (18.4%). No significant association was found between cyst size and pain laterality (P = .161), cyst volume and pain location (P = .546), or cyst size and unilateral vs bilateral pain (P = .997).
CONCLUSION: The increased prevalence of Tarlov cysts is likely not the etiology of pudendal neuralgia, yet both could be due to similar pathogenesis from part of a focal or generalized condition.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Tarlov cyst; chronic pain; genitopelvic pain; lumbosacral cysts; lumbosacral pain; meningeal cysts; pelvic pain; perineural cysts; pudendal nerve; pudendal neuralgia

Year:  2019        PMID: 31319080     DOI: 10.1016/j.ajog.2019.07.021

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

1.  Pudendal tumor mimicking cauda equina syndrome and acute radiculopathy: case report.

Authors:  Uma V Mahajan; Kyle B Labak; Collin M Labak; Eric Z Herring; Kyle Lineberry; Jonathan P Miller; Gabriel Smith
Journal:  Spinal Cord Ser Cases       Date:  2022-08-02

2.  Large presacral Tarlov cysts in pregnancy.

Authors:  Akiyoshi Kanagawa; Hiroko Matsumiya; Mizue Sasaki; Takahiro Koyama; Mie Yamamura; Masashi Moriwaki; Yasumasa Onodera; Yasunari Oda; Mitsuru Sugiura; Takashi Yamada
Journal:  Clin Case Rep       Date:  2022-05-12

3.  Neglected Tarlov cysts: a case of a Tarlov cyst with spermatorrhea.

Authors:  Pan Sun; Wangbing Xu; Yongxiang Ye; Faming Zhong; Xuan Wan; Yong Li
Journal:  Eur J Med Res       Date:  2021-05-08       Impact factor: 2.175

4.  Large- and Small-Fiber Neuropathy in Patients with Tarlov Cysts.

Authors:  Mieke Hulens; Frans Bruyninckx; Dietmar Rudolf Thal; Ricky Rasschaert; Chris Bervoets; Wim Dankaerts
Journal:  J Pain Res       Date:  2022-01-25       Impact factor: 3.133

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.